AzTrials
AzTrials

TonsillectomyNCT05206799

The CMCPCTH Research in Chinese Children

An observational study of Tonsillectomy and Child, run by Shanghai Children's Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To obtain hemorrhage rate after coblation tonsillectomy, and to investigate risk factors of hemorrhage after coblation tonsillectomy in children. Read more about this study

Who is it for?
Ages Up to 18 years
Conditions the study is for
Tonsillectomy, Child, Postoperative Hemorrhage
How many people
25,000 participants
Where
1 siteChina
Study dates
15 Jan 2022to 28 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Enrolled patiens are children who underwent coblation tonsillectomy from multi-centers in different provinces of China.

Who may be able to join

  • under 18 years old;
  • Clear indications for tonsill surgery;
  • No clear contraindications for tonsill surgery;
  • Parents of the children patients accept surgical treatment;
  • Parents of the children patients able to cooperate with the visit and follow-up.

Who cannot join

  • Children patients with a history of adenoid or tonsillectomy surgery;
  • Associated with refractory bleeding diseases;
  • Combined with cleft palate;
  • Down syndrome, Prader-Willi syndrome (PWS) or other chromosomal abnormalities;
  • Neuromuscular diseases (including cerebral palsy);
  • Other diseases that affect physical health, such as severe heart disease, kidney disease, lung disease, etc;
  • Contraindications to surgery and anesthesia;
  • Unable to obtain informed consent.

Trial locations and contacts

1 site in 1 country.

Xiaoyan Li, PHD contact

+8618917128276

chhshent@163.com

Hongming Xu, PHD contact

+8613917086351

xuhongming@188.com

China1 site, 1 recruiting
  • Children's Hospital of Shanghai

    Shanghai, Shanghai Municipality, 200062

    Hongming Xu, PHD, +8613917086351, xuhongming@188.com

    Recruiting

Other trials in China

About this study

Official title: A Multi-centre Clinical Study of Hemorrhage Rate After Coblation Tonsillectomy in Children

To obtain hemorrhage rate after coblation tonsillectomy, and to investigate risk factors of hemorrhage after coblation tonsillectomy in children.

Read the detailed description

This study is a prospective and multi-centre trail in China. It intends to enroll 25000 patients underwent coblation tonsillectomy in 22 clinical centers in China. Hemorrhage rate and risk factors of hemorrhage after coblation tonsillectomy will be investigated through questionnaires.

Keywords
Tonsillectomy, child, Postoperative Hemorrhage, low-temperature plasma radiofrequency ablation
Medical subject headings
Postoperative Hemorrhage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hemorrhage rate after coblation tonsillectomy

    hemorrhage rate after coblation tonsillectomy in children within 3 weeks

    Measured: 3 weeks after surgery

  2. risk factors of hemorrhage after coblation tonsillectomy

    risk factors of hemorrhage after coblation tonsillectomy in children

    Measured: 3 weeks after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2022
  2. Study start15 Jan 2022
  3. Primary completion14 Jan 2024 (estimated)
  4. Study completion28 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
25,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05206799
Sponsor's protocol ID
2021R096-E01
Status last verified
Jan 2022
First submitted
12 Jan 2022
Last updated
15 Nov 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Yiu Y, Mahida JB, Cooper JN, Elsey NM, Deans KJ, Minneci PC, Merrill TB, Tobias JD, Elmaraghy CA. The effect of perioperative dexamethasone dosing on post-tonsillectomy hemorrhage risk. Int J Pediatr Otorhinolaryngol. 2017 Jul;98:19-24. doi: 10.1016/j.ijporl.2017.04.033. Epub 2017 Apr 24.

    PubMed 28583496
  • Sarny S, Ossimitz G, Habermann W, Stammberger H. Hemorrhage following tonsil surgery: a multicenter prospective study. Laryngoscope. 2011 Dec;121(12):2553-60. doi: 10.1002/lary.22347.

    PubMed 22109752
  • Soderman AC, Odhagen E, Ericsson E, Hemlin C, Hultcrantz E, Sunnergren O, Stalfors J. Post-tonsillectomy haemorrhage rates are related to technique for dissection and for haemostasis. An analysis of 15734 patients in the National Tonsil Surgery Register in Sweden. Clin Otolaryngol. 2015 Jun;40(3):248-54. doi: 10.1111/coa.12361.

    PubMed 25515059
  • Inuzuka Y, Mizutari K, Kamide D, Sato M, Shiotani A. Risk factors of post-tonsillectomy hemorrhage in adults. Laryngoscope Investig Otolaryngol. 2020 Nov 14;5(6):1056-1062. doi: 10.1002/lio2.488. eCollection 2020 Dec.

    PubMed 33364394
  • Xu H, Qiu S, Pu S, Hu B, Liu D, Li X. Multicentre clinical study of haemorrhage after coblation tonsillectomy in children: a prospective study protocol. BMJ Open. 2023 Jan 10;13(1):e063401. doi: 10.1136/bmjopen-2022-063401.

    PubMed 36627154

Questions about this trial

What is this clinical trial studying?

An observational study of Tonsillectomy and Child, run by Shanghai Children's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiaoyan Li, PHD (+8618917128276, chhshent@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hemorrhage rate after coblation tonsillectomy (time frame: 3 weeks after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05206799, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in